THE ANTIVENOM COMPANY™

We produce the latest generation
of highly specific biological polyvalent antivenoms

This could be the new Treatment developed in Mexico to neutralize COVID

To stop anyone from suffering or dying as a consequence of animal envenoming
OUR MISSION
We believe that no one should suffer or die as a consequence of animal envenoming. For this reason, we have developed a unique and original platform to make safe, effective, and non-cold chain dependent antivenoms available at a fair price.

We are eager to be part of the solution. We work close to patients along with the medical community, governments, and many international organizations and institutions in order to improve the access to antivenoms and the care for people affected by animal envenoming.
We currently distribute and commercialize our products mainly in Africa and Middle East and we are developing new antivenoms for other regions.

We perform our mission passionately and committed to the integrity wherever we operate. We reflect these values in our products, services, and communication while interacting with people.
Our strategy and products are aligned with the WHO plan to reduce the effects of animal envenoming.
THE TEAM
Juan López de Silanes Blanco
CEO & Founder
Juan López de Silanes y Pérez
Chairman of the board & Founder
Beatriz López de Silanes Blanco
General Counsel & Chief
Compliance Officer
An independent family company.
We care for people, especially those affected by animal envenoming all around the world.
Raúl Soria
VP & COO
Always close to your community sharing our knowledge and training the future experts
18
JULY
Venom Week 2022
July 18-21, 2022
Skysong Center, Scottsdale (Arizona)

ESAA presentation by
Jean-Philippe


23
AGO
Venom & Toxins 2022
August 23-25, 2022
Oxford (UK)

participation of Inosan


16
OCT
World congress of IST 2022
Oct 16-21, 2022
Conrad Abu Dhabi Etihad Towers (United Arab Emirates)

presentation of Inoserp MENA & Inoscorpi MENA by Inosan

PROJECTS CLOSEST TO OUR HEARTS
Snakebites are ‘neglected’ health crisis in Africa
Snakebites kill tens of thousands of Africans a year. Now, an antivenom shortage is spurring global experts to collaborate on treatment and prevention.
Inosan Biopharma
Since our founding we've been working hand by hand with global institutions to bring solutions to communities affected by animal envenoming.
Asclepius Snakebite Foundation
Huge thank you to Inosan Biopharma for donating 200 vials of Inoserp Panafrica polyvalent antivenom to the Asclepius Snakebite Foundation
WHAT´S NEW?
Snakebites are ‘neglected’ health crisis in Africa
Snakebites kill tens of thousands of Africans a year. Now, an antivenom shortage is spurring global experts to collaborate on treatment and prevention.
Inosan Biopharma at the IST 2019
The world in which Inosan Biopharma was created presented a challenge: many pharmaceutical companies.
THE REALITY OF SNAKEBITES – TIME IS TISSUE
With at least 600,000 people worldwide killed or permanently disabled each year, snakebites are the biggest public health crisis that no one has heard of
UCSF Fresno Doctor Studies Venomics for Snakebite Treatment
Ever since he was a little boy, reptiles have fascinated UCSF Fresno emergency physician and medical toxicologist Nicklaus Brandehoff, MD
LANCEMENT D’UNE ÉTUDE AU CAMEROUN POUR ÉVALUER LES SÉRUMS ANTIVENIMEUX
L’étude « Morsures de serpent au Cameroun : Evaluation de Sérum Antivenimeux en Afrique (ESAA) relevé de données en condition de vie réelle
Poisonous animal bites, a public health problem in Mexico
In the current scenario, accidents caused by poisonous animals are already considered a public health problem in Mexico.
Do's and Don'ts in Case of Ophidic Accident
Do you know what to do if you are bitten by a snake? There are many myths about it and in these two minutes Dr. Luis Eduardo Robles Ortíz, MD.

Contact us

Spain


Arbea Business Campus
Building 2, Floor 2
Ctra. Fuencarral a Alcobedas km 3,8
28108 Alcobendas (Madrid), Spain
Tel. (+34) 913 346031

Mexico

Lucerna 7, Col. Juárez
Mexico City, Mexico
(+52) 55 51 40 1535
info@inosanbiopharma.com

With representation in
USA, France, Ghana and Kenya